Skip to content
For research use only. Not for human or veterinary use. Not a drug, food, or dietary supplement.
AMIRAVOResearch Library
Cycle-length evidence

Triptorelin cycle length: what human studies ran

FDA-approvedAHuman trial evidence
Short answer: Triptorelin has no "cycle". As an approved drug it is used as its label and a prescriber direct.

Treatment and follow-up in human studies

No human study durations are recorded.

What has not been tested

  • On-and-off schedules or breaks between courses.
  • Repeated courses and long-term exposure beyond the periods listed.
  • Triptorelin combined with other compounds, unless a study above says so.

Frequently asked questions

Is there an established Triptorelin cycle length?
No cycle is defined. Triptorelin is an approved drug whose label describes treatment under a prescriber's care; the label, not a cycle, governs duration.
What is the longest human study of Triptorelin?
None is recorded.
Do study durations tell me how long to use something?
No. A study duration is how long investigators administered a compound to selected participants under monitoring. It is not a recommended course, and a break between courses has not been tested for any compound on this site that is not approved.
Triptorelin dosing reference Full research page

References

  1. TRELSTAR (triptorelin pamoate for injectable suspension) prescribing information (DailyMed, effective 06/2026) FDA label (DailyMed). 2026
  2. TRIPTODUR (triptorelin) for extended-release injectable suspension prescribing information (DailyMed, effective 09/2025) FDA label (DailyMed). 2025
  3. Drugs@FDA (openFDA) application records for triptorelin (NDA 020715, 021288, 022437, 208956) U.S. FDA. 2026
  4. Comparative efficacy of triptorelin pamoate and leuprolide acetate in men with advanced prostate cancer BJU Int. 2003
  5. World Anti-Doping Agency Prohibited List 2026 (online version) WADA. 2026
  6. PubChem compound record for triptorelin PubChem. 2026